Survivorship in Pediatric Oncology Patients

November 12, 2020

Childhood and young adult cancer survivors are more likely to develop chronic conditions compared to siblings of the same age and gender. They are more likely to develop chronic conditions that affect their fertility, heart, lungs, and neurocognitive function. These patients may not present with treatment-related adverse events until years after cancer treatment. This presentation will describe major side effects that pediatric patients can experience, including cardiomyopathy, pulmonary dysfunction, hearing loss, and infertility. We will discuss the agents that are associated with the previously mentioned adverse effects and their management as well as studies that have shown an increase in survival and agents that have been incorporated to prevent long term side effects. We will the close the gap with information and tips to pharmacists on how to address those side effects based on primary literature and references that guide clinicians’ practice.

Target Audience

  • Pharmacists
  • Pharmacy technicians

Learning Objectives

Pharmacist learning objectives

  1. Discuss the epidemiology of pediatric survivorship
  2. Discuss the pathophysiology and adverse effects of chemotherapy-induced long-term side effects
  3. Evaluate literature that improved survivorship in pediatric adolescents, and young adult patients

Pharmacy technician learning objectives

  1. Identify the long-term adverse events of chemotherapy agents in pediatric, adolescent, and young adult cancer survivors
Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
  • 1.00 General CEU – Attendance
Course opens: 
11/12/2020
Course expires: 
12/27/2020
Event starts: 
11/12/2020 - 12:00pm
Event ends: 
11/12/2020 - 1:00pm
Cost:
$0.00
Ochsner Medical Center
New Orleans, LA
United States
Relevant financial relationships: Planning committee members and presenters have nothing to disclose
 
Planning committee members
Bailey Wise, PharmD, BCPS
Clinical Pharmacist
Ochsner Medical Center
 
Kathryn Cook, PharmD, BCPPS
Pediatric Hematology/Oncology Clinical Pharmacist
Ochsner Medical Center
 
Course reviewer
Gretchen Brummel, PharmD, BCPS
Consulting Director, Pharmacy
Vizient
 
Presenter
Jasmin Eugene, PharmD
PGY2 Oncology Pharmacy Resident
Ochsner Medical Center
Joint Accreditation Statement:
 
In support of improving patient care, this activity has been planned and implemented by Vizient, Inc. and Ochsner Medical Center.  Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
____________________________________________
 
Designation Statements:
 
PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-9999-20-214-L01-P
Universal Activity Number: JA0006103-9999-20-214-L01-T
CEU
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
  • 1.00 General CEU – Attendance

Price

Cost:
$0.00
Please login or register to take this course.